- Home
- SYRE vs HUMAW Comparison
SYRE vs HUMAW Comparison
Compare SYRE & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- HUMAW
- Stock Information
- Founded
- SYRE 2013
- HUMAW N/A
- Country
- SYRE United States
- HUMAW United States
- Employees
- SYRE N/A
- HUMAW 185
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- SYRE Health Care
- HUMAW Health Care
- Exchange
- SYRE Nasdaq
- HUMAW Nasdaq
- Market Cap
- SYRE N/A
- HUMAW N/A
- IPO Year
- SYRE 2016
- HUMAW 2020
- Fundamental
- Price
- SYRE $23.70
- HUMAW $1.44
- Analyst Decision
- SYRE Strong Buy
- HUMAW
- Analyst Count
- SYRE 8
- HUMAW 0
- Target Price
- SYRE $51.50
- HUMAW N/A
- AVG Volume (30 Days)
- SYRE 600.7K
- HUMAW N/A
- Earning Date
- SYRE 02-27-2025
- HUMAW N/A
- Dividend Yield
- SYRE N/A
- HUMAW N/A
- EPS Growth
- SYRE N/A
- HUMAW N/A
- EPS
- SYRE N/A
- HUMAW N/A
- Revenue
- SYRE N/A
- HUMAW N/A
- Revenue This Year
- SYRE $168.62
- HUMAW N/A
- Revenue Next Year
- SYRE $47.61
- HUMAW N/A
- P/E Ratio
- SYRE N/A
- HUMAW N/A
- Revenue Growth
- SYRE N/A
- HUMAW N/A
- 52 Week Low
- SYRE $20.07
- HUMAW N/A
- 52 Week High
- SYRE $47.97
- HUMAW N/A
- Technical
- Relative Strength Index (RSI)
- SYRE 54.71
- HUMAW N/A
- Support Level
- SYRE $21.67
- HUMAW N/A
- Resistance Level
- SYRE $22.81
- HUMAW N/A
- Average True Range (ATR)
- SYRE 1.42
- HUMAW 0.00
- MACD
- SYRE 0.40
- HUMAW 0.00
- Stochastic Oscillator
- SYRE 96.23
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.